Co-Authors
This is a "connection" page, showing publications co-authored by Davide Mangioni and Stefano Aliberti.
Connection Strength
0.287
-
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. 2021 08 10; 6(62).
Score: 0.060
-
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes. Front Immunol. 2020; 11:560330.
Score: 0.057
-
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J Allergy Clin Immunol. 2021 Feb; 147(2):561-566.e4.
Score: 0.057
-
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med. 2020 12; 175:106204.
Score: 0.057
-
Use of anakinra in severe COVID-19: A case report. Int J Infect Dis. 2020 Jul; 96:607-609.
Score: 0.055